May 6, 2020
DongWha Pharm’s plans testing new drug candidate to treat COVID-19
DongWha Pharm’s said it is getting ready for second phase of clinical trials of new drug candidate DW2008 to treat COVID-19.
Pharmaceuticals, Biotechnology and Life Sciences
DongWha Pharm’s said it is getting ready for second phase of clinical trials of new drug candidate DW2008 to treat COVID-19.